Oriental Aquamarine Biotech India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 23-12-2024
- Paid Up Capital ₹ 0.10 M
as on 23-12-2024
- Company Age 20 Year, 9 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 5.71 M
as on 23-12-2024
- Revenue -49.96%
(FY 2022)
- Profit -7.58%
(FY 2022)
- Ebitda -11.31%
(FY 2022)
- Net Worth
- Total Assets 5.30%
(FY 2022)
About Oriental Aquamarine Biotech India
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.71 M.
Usha Mohan and Krishnamurthy Kandaswamy serve as directors at the Company.
- CIN/LLPIN
U05004TZ2004PTC011077
- Company No.
011077
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Apr 2004
- Date of AGM
29 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Coimbatore, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Oriental Aquamarine Biotech India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishnamurthy Kandaswamy  | Director | 07-Apr-2004 | Current |
| Usha Mohan | Director | 07-Apr-2004 | Current |
Financial Performance of Oriental Aquamarine Biotech India.
Oriental Aquamarine Biotech India Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 49.96% decrease. The company also saw a slight decrease in profitability, with a 7.58% decrease in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oriental Aquamarine Biotech India?
Unlock access to Oriental Aquamarine Biotech India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Ministry Of Science & Technology Creation Date: 22 Oct 2012 | ₹4.21 M | Open |
Department Of Biotechnology Creation Date: 08 Apr 2009 | ₹1.50 M | Open |
How Many Employees Work at Oriental Aquamarine Biotech India?
Unlock and access historical data on people associated with Oriental Aquamarine Biotech India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oriental Aquamarine Biotech India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oriental Aquamarine Biotech India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
